The effectiveness of the Liverpool care pathway in improving end of life care for dying cancer patients in hospital. A cluster randomised trial.
BACKGROUND
Most cancer patients still die in hospital, mainly in medical wards. Many studies in different countries have shown the poor quality of end-of-life care delivery in hospitals. The Program "Liverpool Care Pathway for the dying patient" (LCP), developed in the UK to transfer the hospice model of care into hospitals and other care settings, is a complex intervention to improve the quality of end-of-life care. The results from qualitative and quantitative studies suggest that the LCP Program can improve significantly the quality of end-of-life care delivery in hospitals, but no randomised trial has been conducted till now.


METHODS
This is a randomized cluster trial, stratified by regions and matched for assessment period. Pairs of eligible medical wards from different hospitals will be randomized to receive the LCP-I Program or no intervention until the end of the trial. The LCP-I Program will be implemented by a Palliative Care Unit.The assessment of the end-points will be performed for all cancer deaths occurred in the six months after the end of the LCP-I implementation in the experimental wards and, in the same period of time, in the matched control wards. The primary end-point is the overall quality of end-of-life care provided on the ward to dying cancer patients and their families, assessed using the Global Scale of the Italian version of the Toolkit "After-death Bereaved Family Member Interview".


CONCLUSIONS
This study can be interpreted as a Phase III trial according to the Medical Research Council Framework. In this study, the effectiveness of a fully defined intervention is assessed by comparing the distribution of the endpoints in the experimental and in the control arm. RESEARCH ID: RFPS-2006-6-341619


BACKGROUND
ClinicalTrials.gov Identifier: NCT01081899.
Regional Palliative Care Network, National Cancer Research Institute, Genoa, Italy. massimo.costantini@istge.it
Massimo
M
Costantini
Simona
S
Ottonelli
Laura
L
Canavacci
Fabio
F
Pellegrini
Monica
M
Beccaro
D016000:Cluster Analysis; D019091:Critical Pathways; D004739:England; D006801:Humans; D009369:Neoplasms; D010166:Palliative Care; D015397:Program Evaluation / Q000379:methods; D011785:Quality Assurance, Health Care; D013727:Terminal Care / Q000592:standards*
Int J Palliat Nurs. 2006 Sep;12(9):414-21
17077800
BMC Palliat Care. 2008 Jul 11;7:8
18620567
Int J Palliat Nurs. 2004 Oct;10(10):502-6
15577711
BMJ. 2008 Sep 29;337:a1655
18824488
Palliat Med. 2005 Dec;19(8):628-38
16450880
BMJ. 2003 Jan 4;326(7379):30-4
12511460
BMJ. 2007 Mar 3;334(7591):455-9
17332585
Int J Palliat Nurs. 2003 Sep;9(9):375-81
14593273
Support Care Cancer. 2008 Feb;16(2):113-22
17917746
Eur J Oncol Nurs. 2006 Feb;10(1):48-58
16006186
J Pain Symptom Manage. 2001 Sep;22(3):738-51
11532587
J Epidemiol Community Health. 2006 May;60(5):412-6
16614331
J Pain Symptom Manage. 2010 Jun;39(6):1003-15
20538184
Palliat Med. 2008 Mar;22(2):145-51
18372379
J Pain Symptom Manage. 2001 Sep;22(3):752-8
11532588
BMJ. 1998 Jan 10;316(7125):133-7
9462322
Am J Hosp Palliat Care. 2008 Jun-Jul;25(3):207-14
18403578
Qual Saf Health Care. 2002 Sep;11(3):270-5
12486994
J Pain Symptom Manage. 2005 Jul;30(1):33-40
16043005
Stat Med. 1999 Apr 15;18(7):855-88
10327531
Arch Intern Med. 2005 Aug 8-22;165(15):1722-7
16087819
J Palliat Med. 2000 Fall;3(3):287-300
15859670
J Pain Symptom Manage. 2001 Dec;22(6):1035-41
11738166
J Pain Symptom Manage. 2005 Jun;29(6):529-43
15963861
JAMA. 2004 Jan 7;291(1):88-93
14709580
BMC Palliat Care. 2006 Oct 02;5:7
17014714
Ann Intern Med. 1997 Jan 15;126(2):97-106
9005760
BMJ. 2000 Sep 16;321(7262):694-6
10987780
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD008006
20091660
Clin Trials. 2005;2(2):99-107
16279131
Hastings Cent Rep. 2006 Jul-Aug;36(4):S1-40
16898359
J Health Serv Res Policy. 2000 Jan;5(1):12-6
10787581
Singapore Med J. 2005 May;46(5):210-4
15858688